Founded Year

2014

Stage

Series E | Alive

Total Raised

$764.74M

Valuation

$0000 

Last Raised

$514M | 4 yrs ago

Revenue

$0000 

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-70 points in the past 30 days

About Medlinker

Medlinker focuses on digital healthcare, operating within the healthcare and technology sectors. The company offers a range of services, including a digital hospital and an AI doctor, which utilize internet technology, AI, and big data to provide long-term, standardized management services for chronic disease patients. Medlinker primarily serves the healthcare industry. It was founded in 2014 and is based in Chengdu, Sichuan.

Headquarters Location

Floor 2, Block B6, Tianfu Software Park, No.99 Tianhua First Road

Chengdu, Sichuan, 610041,

China

(86 28) 83350767

Loading...

Loading...

Expert Collections containing Medlinker

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medlinker is included in 3 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,309 items

D

Digital Health

12,122 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

T

Telehealth

3,123 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest Medlinker News

斩获“医药界诺贝尔奖”盖伦奖提名, 未来医生以创新实力带领中国医疗AI首登世界舞台

Nov 11, 2025

斩获“医药界诺贝尔奖”盖伦奖提名, 未来医生以创新实力带领中国医疗AI首登世界舞台 图片来源:Prix Galien 创新模式: “真人医生 + AI 辅助 + 责任闭环”,攻克医疗 AI 信任难题 全球医疗系统正面临严峻挑战:资源分布不均、服务成本上升以及误诊风险存在。传统医疗服务模式已难以满足日益增长的健康需求。 同时,AI 在医生监督下执行任务,医生可实时签署或修改结果,形成“AI建议 ― 医生审核并签名”的责任闭环。这样一来,反复的记录与整理工作前置到系统,医生只需要把精力更多放在需要临床经验与综合判断的环节(鉴别诊断、方案取舍、沟通与随访)。 而该模式的具体流程为,用户发起问诊后,平台会按“医生主导、AI辅助”的流程运行,包含前期的病情收集与初分诊、MDT 召集与主诊专科确定、专科接诊与处置。一般简单病/常见病会由专家团队医生在 AI 辅助下给出诊断与医嘱并签署,复杂病/罕见病则由专家团队医生升级转派至专家本人接诊并最终签署。同时,在任何阶段一旦系统或医生识别到“红旗症状”,立即触发急危重症提醒,未来医生会指导用户拨打 120 或直达急诊,并同步生成要点交接信息。 整个链条可追溯、可审计,医生的签署与复核明确了责任边界,也让协作更稳。 这让AI从“辅助工具”真正升级为医生的受托助手,实现了医学伦理与人工智能工程的第一次结合。这种“法律责任闭环”也打破了医疗AI领域的信任壁垒,使未来医生从工具型应用升级为负责任的服务平台。 技术硬核:医疗大模型MedGPT获全球第一认证,筑牢临床安全底座 未来医生的技术核心医疗大模型MedGPT,是国内首个获批用于提供疾病诊断与治疗建议的生成式AI模型算法之一。该模型基于Transformer架构,早在2023年与华西医院真人医生的诊断率一致性就已达到96%。 传统医疗AI模型普遍存在“幻觉问题”,即可能生成看似合理但实际错误的医疗建议。未来医生通过其独创的快慢双系统架构与人机结合模式,有效解决了这一行业难题。 快系统调用多基座大语言模型实现自然语义交互,解决“听懂人话”的问题;慢系统则基于RAG检索增强生成技术,依托自有医学知识图谱、专家共识等资源,对快系统的输出进行校验修正,彻底规避通用AI“一本正经胡说八道”的风险。同时,所有AI生成的内容都会由医生最终把关。 两个系统协同工作,既保证了问诊效率,又确保了医疗安全。 而该功能因需医生与AI深度协作,托管率达98%-99%,竞争对手需突破 “技术攻克 + 医生签约 + 授权体系打磨”三重难关,仅“打磨周期”就需至少6个月,且依旧无法完全复刻效果。 2025年8月,中国医疗科技企业医联集团(Medlinker)在康奈尔大学Arxiv平台正式发表最新研究成果――自主研发的医疗大模型MedGPT在国际权威对比评测中全面超越OpenAI-o3,成为该领域全球第一。 这一评测首次让 AI 在真实医疗交互场景中接受全面验证,为未来医生登上盖伦奖舞台奠定了技术与学术双重基础。 未来医生通过四大核心应用场景,重塑了患者对医疗AI的信任。 比如在自检自查场景中,未来医生可模拟全科医生问诊思路,在患者描述症状后持续追问,自动归纳出病情线索,结合医生共识与指南进行风险分级,最终给出初步评估和专业建议。对于小症状大问题,能有效进行风险排查,对于大症状小问题,能给出自检自查方法,帮助患者减少焦虑。 在体检报告解读方面,未来医生可在数分钟内完成自动识别与结构化分析,标出异常指标并结合病史与年龄生成健康风险评估,医生团队复核后出具解释说明与随访建议。帮助患者提前识别健康风险,让异常指标恢复正常,做好长期健康管理。 在二次诊疗意见服务中,未来医生平台上的专家团队可基于AI的初步分析,对疑难杂症进行深度复核与综合研判,出具明确的、负责的、权威的二次诊疗意见,降低错诊、误诊和漏诊风险。 在慢病管理领域,未来医生通过AI系统与医生共训机制,建立个体化的“健康稳态模型”:它会识别患者在用药反应、实验室指标、症状记录中的微小波动,提示医生在失衡前介入;AI则负责数据整合与趋势判断,医生完成方案调整与签章确认。为患者提前干预关键风险,避免并发症,帮助其重建“稳态”。 在以上常见的四类场景里,患者不仅能得到一次性的答复,还能在同一入口获得连续性的健康管理。因此,于患者而言,未来医生已经真正成为一个可及与可托付的平台。医疗AI的风险不再由患者承担,而是回到医生专业责任体系内,患者可以信任系统结果,因为背后站着真正的医生。 普惠革新:打破壁垒,让稀缺优质医疗服务人人可及

Medlinker Frequently Asked Questions (FAQ)

  • When was Medlinker founded?

    Medlinker was founded in 2014.

  • Where is Medlinker's headquarters?

    Medlinker's headquarters is located at Floor 2, Block B6, Tianfu Software Park,, Chengdu.

  • What is Medlinker's latest funding round?

    Medlinker's latest funding round is Series E.

  • How much did Medlinker raise?

    Medlinker raised a total of $764.74M.

  • Who are the investors of Medlinker?

    Investors of Medlinker include Sino Biopharmaceutical, HongShan, China Renaissance, China Health Industry Investment Fund, China Capital Zhongcai Fund Management and 9 more.

  • Who are Medlinker's competitors?

    Competitors of Medlinker include All-In-One Clinic, Xikang, Helowin, Zhiyun Health, We Doctor and 7 more.

Loading...

Compare Medlinker to Competitors

ABC Clinic Manager Logo
ABC Clinic Manager

ABC Clinic Manager is a digital healthcare solutions provider that offers clinic management systems and AI-integrated diagnostics. The company provides services including patient history databases, healthcare cost management, and optimization of medical resource utilization. Outpatient clinics, hospitals, integrated outpatient departments, community healthcare service stations, and village clinics use its products. It was founded in 2017 and is based in Chengdu, China.

Justhealth Logo
Justhealth

Justhealth develops artificial intelligence (AI) based healthcare software. The company aims to achieve post-diagnosis disease management and service operations. It serves chemicals, food, pharmaceuticals, and agriculture. The company was founded in 2015 and is based in Hangzhou, China.

BeatO Logo
BeatO

BeatO is a healthcare company that focuses on diabetes management and care. The company offers a range of services, including consultations with certified diabetologists, a digital diabetes care program, and tools for continuous health monitoring and management. BeatO also provides diabetes-friendly products and resources such as nutritionist-approved recipes and health-related blog content. It was founded in 2015 and is based in New Delhi, India.

L
Life In Control

Life in Control develops a diabetes management program designed to help doctors drive good patient outcomes. The company's program is scientifically designed for glycemic control and healthy lifestyles and offers an integrated platform for managing diabetes through collaborative care, enabling doctors, health coaches, dietitians, and activity instructors to connect with the patient and the patient's family on a single platform. It is based in Hyderabad, India.

Emperra Logo
Emperra

Emperra operates in the healthcare technology sector. It offers a platform for diabetes management that automates the recording of insulin units and blood sugar levels while allowing for remote monitoring and therapy adjustments by healthcare professionals. The company serves the healthcare industry, specifically in the area of diabetes care. It was founded in 2008 and is based in Potsdam, Germany.

One Drop Logo
One Drop

One Drop operates is a diabetes management platform. It allows users to track their glucose levels using a variety of devices, including blood glucose meters, continuous glucose monitors (CGMs), and insulin pumps. It also offers a mobile application that provides personalized coaching to help users achieve their health goals. The company was founded in 2015 and is based in New York, New York.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.